Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | company profile
Premium Company Profile - Pain Therapeutics (Datamonitor)
- Market: Healthcare and Medical
- Published Date: 31/10/2007
- Report Title: Premium Company Profile - Pain Therapeutics
- Table of Contents: View Table of Contents
- Report Type: Company Profile
- Country: Global
- Number of Pages: 43
Introduction
Pain Therapeutics was initially focused on building a franchise of pain management products through partnering with the scientific and medical community. In 2006, Pain Therapeutics changed its focus from being a clinical research based company to becoming a fully integrated biopharmaceutical franchise through in-licensing activities.
Scope
Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights
Pain Therapeutics is focused on the development and commercialization of pharmaceutical products for pain management and hematology/oncology indications. The company has three investigational drug candidates in clinical programs, namely, Remoxy and PTI-202 which are in the Phase III and Phase I stage respectively.
Pain Therapeutics derives its revenues mainly from program fee and collaboration related to the strategic alliance with King Pharmaceuticals for the development and commercialization of Remoxy and other abuse-resistant opioid painkillers.
The company's total revenues increased significantly during the fiscal year 2006, from $5 million in 2005 to $54 million in 2006 The company's major contributor to the revenues during 2006 was program fee related to the strategic alliance with King Pharmaceuticals, which recorded revenues of $26 million during 2006.
Reasons to Purchase
Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization
Scope
Highlights
Reasons to Purchase
Purchase Information
There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.
Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.
Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
